A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
Completed · Phase 3
Conditions studied: Acute Pain
In brief
Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA (patient-controlled analgesia) administration, or both, as determined by the investigator, for a duration not to exceed 14 days.
Key facts
- Study ID
- NCT02656875
- Run by
- Trevena Inc.
- People needed
- 768
- Starts
- 2015-12-01
- Expected to finish
- 2017-08-01
- Last updated by the study team
- 2020-09-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Recruiting — Mobile, Alabama, United States
- Recruiting — Pasadena, California, United States
- Recruiting — Miami, Florida, United States
- Recruiting — Shreveport, Louisiana, United States
- Recruiting — Jackson, Mississippi, United States
- Study site — Staten Island, New York, United States
- Recruiting — State College, Pennsylvania, United States
- Study site — Houston, Texas, United States
- Study site — Houston, Texas, United States
- Recruiting — Murray, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.